华平信息技术股份有限公司 公告 关于 2023 年股票期权激励计划第二个行权期行权条件成就的公告 本公司及其董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 特别提示： （一）本次符合股票期权行权资格的激励对象人数：60名。 （二）本次可行权的股票期权数量：420.20万份。 （三）本次可行权的股票期权的行权价格：3.30元/股。 （四）本次可行权的股票期权的行权方式：自主行权。 本次可行权的股票期权尚需公司按规定办理行权手续之后方可行权，届时公司 将另行公告，敬请投资者关注。 华平信息技术股份有限公司（以下简称"公司"）于2025年8月26日召开第六届 董事会第三次会议，审议通过《关于2023年股票期权激励计划第二个行权期行权条 件成就的议案》，根据《上市公司股权激励管理办法》《深圳证券交易所创业板上 市公司自律监管指南第1号—业务办理》《2023年股票期权激励计划（草案）》的有 关规定，2023年股票期权激励计划（以下简称"本激励计划"）授予的股票期权于 第二个行权期满足行权条件，符合股票期权行权资格的激励对象共计60名，可行权 的股票期权数量共计420.20万份，有关情 ...

福建龙净环保股份有限公司监事会 行办法》 、《中华人民共和国证券法》《上市公司股权激励 管理办法》 关于公司 2024 年股票期权激励计划预留授予事项的核查意见 福建龙净环保股份有限公司（以下简称"公司"）监事会根据《中华人民共和 国公司法》（以下简称《公司法》） 《关于规范国有控股上市公司实施股权激励制度有关问题的通知》等相关 法律、法规和规范性文件以及《公司章程》 《2024 年股票期权激励计划（草案）》 （以 （以下简称《管理办法》）、 《国有控股上市公司（境内）实施股权激励试 》的相关规定。 二、本次预留授予激励对象的基本情况属实，不存在虚假、故意隐瞒或致人重 大误解之处；本次预留授予激励对象均具备《公司法》、 《管理办法》等法律、法规 和规范性文件规定的任职资格；均不存在《管理办法》第八条规定的不得成为激励 对象的情形。 三、本次预留授予激励对象不包含公司独立董事、监事、单独或合计持有公司 综上，公司监事会认为，本次预留授予激励对象主体资格合法、有效，满足获 授股票期权的条件。监事会同意本次预留授予激励对象名单，同意以 2025 年 8 月 为 11.95 元/股。 下简称《激励计划（草案）》）的相 ...

Core Viewpoint - The company has announced that the conditions for the first exercise period of the 2024 stock option incentive plan have been met, allowing for the exercise of 1,007,000 stock options [1][9][11]. Group 1: Stock Option Plan Details - The stock options to be exercised amount to 1,007,000 shares, which will be sourced from the issuance of A-shares to the incentive recipients [1]. - The first exercise period for the stock options is set to last from 12 months after the grant date until the last trading day of the 24-month period, with a 50% exercise ratio [6][9]. - The performance assessment for the incentive plan covers the fiscal years 2024 and 2025, with specific revenue and profit growth targets set for each year [8][10]. Group 2: Performance Conditions - For the first exercise period, the company must achieve either a net profit growth of at least 11.43% or a revenue growth of no less than 7.00% compared to the previous year [8]. - The second exercise period will require a net profit growth of at least 15.00% or a similar revenue growth target [8]. Group 3: Approval and Compliance - The board of directors and the supervisory board have approved the necessary resolutions regarding the stock option plan and its implementation [2][4][10]. - The company has confirmed that all incentive recipients meet the eligibility criteria as per the relevant regulations and internal guidelines [10][11]. Group 4: Legal and Financial Advisory - Legal opinions confirm that the adjustments and actions taken regarding the stock option plan comply with applicable laws and regulations [12]. - The independent financial advisor has also verified that the conditions for the first exercise period have been met and that the necessary approvals have been obtained [12].

Core Points - The company has initiated its 2023 stock option incentive plan, with the first grant and reserved grant details disclosed [1][2][3] - A total of 338 eligible participants can exercise 15,946,000 stock options, representing 0.55% of the total share capital, at an exercise price of 9.36 yuan per share [1][6] - The reserved grant allows 9 eligible participants to exercise 302,500 stock options, accounting for 0.01% of the total share capital, also at an exercise price of 9.36 yuan per share [1][6] Approval Process - The stock option incentive plan underwent several board meetings for approval, including the review of the plan draft and management methods [2][3] - Independent directors and the supervisory board provided their consent and verification for the plan [2][3] Adjustments and Cancellations - The exercise price was adjusted from 9.73 yuan to 9.36 yuan due to the company's profit distribution plans [5] - A total of 2,200,000 stock options were canceled due to 19 participants leaving the company and 239,000 options due to performance assessment failures [5][6] Performance Conditions - The first exercise period is defined as starting from the first trading day after 20 months from the grant date until the last trading day within 32 months [6] - The performance conditions for exercising options include no adverse audit opinions and meeting specific financial performance metrics [6][8] Impact on Company - The exercise of these options is not expected to significantly impact the company's shareholding structure [16] - If all options are exercised, the total share capital will increase by 1,624,850 shares, with minimal effect on earnings per share and return on equity [16] Reporting and Compliance - The company will disclose changes in incentive participants, adjustments to stock option parameters, and exercise situations in regular or temporary reports [17]

Core Viewpoint - The company has approved the 2024 stock option incentive plan and confirmed the eligibility of the reserved grant recipients through a compliance review by the remuneration and assessment committee [1][2]. Disclosure and Review Process - The company held meetings on August 14, 2025, to discuss and approve the stock option incentive plan for 2024, including the list of reserved grant recipients [1]. - The remuneration and assessment committee verified the list of recipients, their identification documents, employment contracts, and positions held within the company and its subsidiaries [1]. - The public disclosure of the reserved grant recipients' names and positions was conducted in accordance with the relevant regulations [1]. Compliance with Regulations - The remuneration and assessment committee concluded that the public disclosure process for the 2024 stock option incentive plan was legal and compliant [2]. - All reserved grant recipients meet the qualifications set forth by relevant laws and regulations, ensuring their eligibility for the incentive plan [2].

Core Points - The company has announced the first exercise period of its 2024 stock option incentive plan, allowing 39 eligible participants to exercise a total of 2.71488 million stock options at a price of 21.20 yuan per share [1][2][3] - The exercise will be conducted through a self-exercise model, with the stock options sourced from a directed issuance of A-shares [1][2][3] - The exercise period is set from August 29, 2025, to August 28, 2026, and the company has completed the necessary registration with the Shenzhen Securities Registration and Clearing Company [2][3] Summary by Sections Stock Option Details - Stock option code: 036574, abbreviated as "Shanshui JLC1" [1][4] - Total number of stock options available for exercise: 2.71488 million [2][3] - Exercise price set at 21.20 yuan per share [3] Impact on Company - The exercise of stock options will not significantly affect the company's shareholding structure or its listing conditions [5] - The financial impact of the stock options will be minimal on basic earnings per share and return on equity, with expenses recognized according to accounting standards [5] - The company will use the funds raised from the exercise to supplement its working capital, and individual income tax will be handled through withholding by the company [5][6] Compliance and Reporting - The company has signed a service agreement with Guosen Securities for the self-exercise process, ensuring compliance with operational requirements [6] - Regular updates on the status of stock option exercises and changes in incentive participants will be disclosed in periodic reports [6]

Group 1 - The company has conducted a review of the list of incentive recipients for the 2025 stock option incentive plan, ensuring compliance with relevant laws and regulations [1][2] - The review confirmed that the selected incentive recipients meet the criteria set forth in the company's incentive plan draft and applicable regulations [2] - The company plans to grant 300,000 stock options to 5 incentive recipients on August 25, 2025, with an exercise price of 57.689 yuan per share [2] Group 2 - The monitoring committee outlined specific disqualifications for incentive recipients, including recent inappropriate designations by the stock exchange or regulatory bodies, and legal restrictions [1] - The committee's opinion supports the alignment of the incentive recipients with the standards approved in the company's first extraordinary general meeting of 2025 [2]

北京万东医疗科技股份有限公司 激励对象名单（预留授予日） 一、激励对象名单及分配情况 占本激励计划拟 占本激励计划 获授的股票期权 二、核心骨干人员、董事会认为需要激励的其他人员名单（以下排名不分先后） 序号 姓名 激励对象类别 北京万东医疗科技股份有限公司 董事会 数量（万份） 量的比例 本总额的比例 核心骨干人员（14 人） 120 11.11% 0.17% 注：上表中部分合计数与各明细数相加之和在尾数上如有差异，系百分比结果四舍五入所致。 职 务 授出全部权益数 预留授予时股 ...

| 司 | | | --- | --- | | 公司业绩考核要求： 2024 年营业收入 | 业收入平均值为 | | 三 第二个行权期业绩考核目标：以 2018-2020 年营业收 | 735,597.77 万元，较 | | 入均值为基数，2024 年营业收入增长率不低于 120%。 | 2018 年-2020 年营业 | | 收 入 均 值 增 长 | | | 业绩考核达成。 | | | 各业务单元/部门层面绩效考核要求： | | | 激励对象当年实际可行权的股票期权数量与其所属 | | | 业务单元/部门层面绩效考核相挂钩，各业务单元/部门层 | | | 面的绩效考核内容、方法、目标由公司决定。本激励计划 | 公司各业务单元/部 | | 授予的股票期权，在考核期内分年度对各业务单元/部门层 | 门层面绩效考核均 | | 四 面进行绩效考核，所属业务单元/部门层面绩效考核必须达 | 达标，满足各业务单 | | 标作为该业务单元/部门内激励对象的行权条件。 | 元/部门层面行权条 | | 期权的行权条件达成，则该业务单元/部门内激励对 | 件。 | | 象按照计划规定比例行权。反之，若行权条件未达成，则 | ...

本激励计划有效期自股票期权授权之日起至激励对象获授的股票期权全部行权或注销之日止，最长不超 过60个月。 格隆汇8月22日丨晶澳科技(002459.SZ)公布2025年股票期权激励计划(草案)，本激励计划拟向激励对象 授予的股票期权数量16,177.6185万份，约占本激励计划草案公告时公司股本总额330,968.16万股的 4.89%。本激励计划权益为一次性授予，无预留权益。本激励计划授予股票期权的行权价格为9.15元/ 份。 本激励计划由公司及与激励对象签署劳动合同的控股子公司作为实施主体，参与对象为公司(含控股子 公司)董事、高级管理人员、核心技术人员以及核心骨干人员，共计1,975人。 ...